Our Services
Medical Information
Helpful Resources
Published on: 4/21/2026
Botox injections may ease chronic postherpetic neuralgia by blocking neurotransmitter release and dampening overactive nerve signals, with studies reporting up to 50–75% pain reduction lasting three to six months. This targeted, off-label approach can offer relief when first-line treatments fail or cause intolerable side effects.
There are several factors to consider, including candidacy criteria, injection technique, potential side effects, costs, and alternative options, so see below for more important details before making any healthcare decisions.
Shingles (herpes zoster) can leave lingering nerve pain known as postherpetic neuralgia (PHN). For some people, conventional painkillers and nerve medications don't offer enough relief. Lately, Botox for shingles nerve pain has emerged as a potential option. This article reviews what the science says, how it works, and whether it might be right for you.
When the varicella-zoster virus reactivates later in life, it causes shingles—a painful, blistering rash along a nerve path. In many cases, even after the rash heals, the affected nerves remain damaged or over-active. This results in:
This chronic nerve pain (PHN) affects sleep, mood, and daily activities. While first-line treatments include anticonvulsants (e.g., gabapentin), antidepressants (e.g., amitriptyline), and topical lidocaine or capsaicin, not everyone gets adequate relief.
If you're experiencing symptoms and want to better understand your condition, Ubie offers a free AI-powered assessment tool for Shingles (Herpes Zoster) that can help you identify your symptoms and explore potential treatment options.
Botox is best known for smoothing wrinkles through temporary muscle relaxation. However, it also affects nerve signaling:
These actions suggest Botox could ease the abnormal nerve firing seen in PHN, leading to reduced pain intensity and improved quality of life.
Although Botox use in PHN is off-label, several studies have explored its effectiveness:
Small Randomized Controlled Trial
Open-Label Pilot Study
Case Series
Overall, these studies suggest that Botox for shingles nerve pain can offer moderate pain relief, especially for patients not fully helped by standard therapies. Pain reduction often begins within 1–2 weeks, peaks around 4–6 weeks, and can last 3–6 months.
Botox injections aren't for everyone. You might consider discussing this approach with your doctor if:
A thorough evaluation by a pain specialist or dermatologist is key. They'll assess your health history, current medications, and rash/nerve damage pattern before recommending injections.
Consultation
Mapping the Pain Area
Injection Technique
Post-Injection Care
Follow-Up
Botox injections are generally well tolerated, but you should be aware of:
Discuss any history of neuromuscular disorders (e.g., myasthenia gravis) with your provider, as Botox could worsen muscle weakness.
Current evidence indicates that Botox for shingles nerve pain can reduce chronic PHN symptoms in select patients, with relief lasting several months. While not a first-line therapy, it offers a targeted approach for those who haven't found sufficient relief from oral or topical treatments.
Before pursuing Botox injections:
Finally, always speak to a doctor about any new or worsening symptoms, especially if you experience severe pain, signs of infection, or neurological changes. Early intervention can prevent complications and improve your quality of life.
(References)
* Wu B, Li G, Wu W, Jiang X. Botulinum Toxin Type A for the Treatment of Postherpetic Neuralgia: A Review of the Literature. Toxins (Basel). 2017 May 25;9(6):170. PMID: 28555138.
* Ding S, Li Z, Yu G, Zhao S. Botulinum Toxin Type A for Pain Management in Postherpetic Neuralgia: A Systematic Review and Meta-Analysis. Pain Pract. 2019 Jun;19(5):549-556. PMID: 30672583.
* Klein A, Seshadri M, Gupta D. Botulinum toxin for the treatment of postherpetic neuralgia: a review of the current evidence. Expert Rev Neurother. 2017 May;17(5):497-502. PMID: 28387087.
* Jabbari B, Choksi I, Gracies JM, Abel T, Putzolu V, Davila G. Botulinum toxin type A for the treatment of postherpetic neuralgia: A randomized, double-blind, placebo-controlled study. J Am Acad Dermatol. 2014 Mar;70(3):525-32. PMID: 23746671.
* Park J, Kim K, Kim YC. Botulinum toxin A in the treatment of postherpetic neuralgia. Pain Physician. 2011 Jul-Aug;14(4):379-84. PMID: 21857677.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.